A Pharmacokinetic Study of TRK-100STP [Beraprost]-A Single Oral Administration Study in Japanese Patients With Renal Impairment as Compared to Subjects With Normal Renal Function

Trial Profile

A Pharmacokinetic Study of TRK-100STP [Beraprost]-A Single Oral Administration Study in Japanese Patients With Renal Impairment as Compared to Subjects With Normal Renal Function

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Beraprost (Primary)
  • Indications Arterial occlusive disorders; Embolism and thrombosis; Peripheral vascular disorders; Pulmonary hypertension
  • Focus Pharmacokinetics
  • Sponsors Astellas Pharma; Toray Industries
  • Most Recent Events

    • 28 Sep 2016 Results of this trial, published in the Journal of Clinical Pharmacology.
    • 03 Mar 2014 Status changed from recruiting to completed as reported by Clinicaltrials.gov record.
    • 20 Jul 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top